Trial
NCT05348681
A Study to Evaluate RIST4721 in Hidradenitis Suppurativa (HS)
Phase IITERMINATEDSAFETYConfidence: MEDIUM
Sponsor
Aristea Therapeutics, Inc.
Collaborators
—
Condition
Hidradenitis Suppurativa
Intervention
RIST4721
Why stopped
Due to safety findings in ongoing Phase 2 trials.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-06-13